We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$271M
AUM Growth
+$12M
Cap. Flow
+$2.92M
Cap. Flow %
1.08%
Top 10 Hldgs %
46.48%
Holding
72
New
4
Increased
23
Reduced
28
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.83M
2
CELG
Celgene Corp
CELG
+$817K
3
META icon
Meta Platforms (Facebook)
META
+$708K
4
PAYC icon
Paycom
PAYC
+$464K
5
PYPL icon
PayPal
PYPL
+$456K

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$678K
2
PM icon
Philip Morris
PM
+$344K
3
ABBV icon
AbbVie
ABBV
+$330K
4
T icon
AT&T
T
+$302K
5
CVS icon
CVS Health
CVS
+$258K

Sector Composition

Rank Sector Weight
1 Healthcare 24.44%
2 Technology 21.21%
3 Communication Services 10.8%
4 Consumer Staples 10.77%
5 Industrials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$20.9M 7.7%
450,848
-1,332
-0.3% -$60.4K
SYK icon
2
Stryker
SYK
$125B
$16.1M 5.94%
95,266
-501
-0.5% -$84.3K
V icon
3
Visa
V
$684B
$15.8M 5.82%
119,429
+474
+0.4% +$61K
ABT icon
4
Abbott
ABT
$183B
$12.7M 4.69%
208,198
-667
-0.3% -$40.4K
ADP icon
5
Automatic Data Processing
ADP
$106B
$11.6M 4.28%
86,613
-917
-1% -$116K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.36T
$10.9M 4.03%
193,240
+620
+0.3% +$33.7K
ABBV icon
7
AbbVie
ABBV
$443B
$10.6M 3.93%
114,483
-3,377
-3% -$330K
PAYX icon
8
Paychex
PAYX
$41.6B
$9.79M 3.61%
143,962
-1,935
-1% -$125K
CL icon
9
Colgate-Palmolive
CL
$73.1B
$8.88M 3.28%
136,677
-837
-0.6% -$54.8K
PEP icon
10
PepsiCo
PEP
$190B
$8.65M 3.2%
79,402
-400
-0.5% -$41.3K
APD icon
11
Air Products & Chemicals
APD
$65.7B
$7.39M 2.73%
47,370
+100
+0.2% +$16.4K
LOW icon
12
Lowe's Companies
LOW
$117B
$7.24M 2.67%
75,416
+535
+0.7% +$48.4K
JNJ icon
13
Johnson & Johnson
JNJ
$618B
$7.09M 2.62%
58,589
-730
-1% -$91.1K
CNI icon
14
Canadian National Railway
CNI
$76.9B
$6.63M 2.45%
80,789
META icon
15
Meta Platforms (Facebook)
META
$1.42T
$6.59M 2.43%
33,980
+3,920
+13% +$708K
NVO
16
Novo Nordisk
NVO
$208B
$6.55M 2.42%
284,964
-422
-0.1% -$10K
DIS icon
17
Walt Disney
DIS
$167B
$6.45M 2.38%
61,442
+540
+0.9% +$55.2K
NSC icon
18
Norfolk Southern
NSC
$75.4B
$6.28M 2.32%
41,595
+1,854
+5% +$271K
RTX icon
19
RTX Corp
RTX
$290B
$6.2M 2.29%
78,849
+43
+0.1% +$3.37K
ECL icon
20
Ecolab
ECL
$78.1B
$5.83M 2.15%
41,660
+297
+0.7% +$42.8K
CELG
21
DELISTED
Celgene Corp
CELG
$5.65M 2.09%
71,491
+9,835
+16% +$817K
SBUX icon
22
Starbucks
SBUX
$120B
$5.57M 2.06%
113,743
-1,270
-1% -$72.1K
PYPL icon
23
PayPal
PYPL
$48.9B
$5.47M 2.02%
65,885
+5,725
+10% +$456K
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.36T
$5.29M 1.95%
94,860
CTSH icon
25
Cognizant
CTSH
$24.9B
$4.88M 1.8%
61,783
+5,648
+10% +$444K

Similar funds

Dillon & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Dillon & Associates held 72 positions worth $271M, up 4.7% from $259M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Dillon & Associates's Q2 2018 filing shows 4 new, 23 increased, 28 reduced and 3 closed positions. Its largest new stake was NVIDIA: 301,040 shares worth $1.78M. The largest sale was Procter & Gamble, an estimated $678K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.

  • Dillon & Associates's largest Q2 2018 buy was NVIDIA: 301,040 shares worth $1.78M.
  • Dillon & Associates added most to Celgene Corp in Q2 2018, an estimated $817K increase.
  • Dillon & Associates's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $678K.
  • Dillon & Associates fully exited AT&T in Q2 2018, selling an estimated $302K.
  • Dillon & Associates's ten largest holdings make up 46% of its $271M portfolio in Q2 2018.
  • Dillon & Associates opened 4 new positions and closed 3 in Q2 2018.
  • Dillon & Associates's portfolio value rose 4.7% quarter-over-quarter to $271M.

Based on Dillon & Associates's 13F filing for Q2 2018, filed 8 Aug 2018.